Fairvalue-Calculator Fairvalue-Calculator
EN DE

Mid-Atlantic Home Health Network, Inc (MAHN) Fair Value & Analysis

Healthcare · US · Market cap $92.2M

Price$0.5000
Fair Value$0.0800
Upside-84.0%
Quality85/100
Evidence: Medium Range $0.0600 – $0.1000

Fair value as of: Jun 24, 2026

Analysis

Mid-Atlantic Home Health Network, Inc (MAHN) currently trades at $0.5000, while our model-based Fair Value estimate is $0.0800 — implying the stock looks roughly 84.0% overvalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Mid-Atlantic Home Health Network, Inc. provides integrated home health products and services for the home health care industry in Virginia, Maryland, and the District of Columbia. It also provides healthcare staffing and private duty nursing services to hospitals, nursing homes, and other facilities, such as clinics, correctional facilities, and schools. Mid-Atlantic was incorporated as U-Can Resources, Inc. in 1979. The company changed its name to Petro-Sers Corporation in 1993 and to Mid-Atlantic Home Health Network, Inc. in 1994. The company is based in Manassas, Virginia. Mid-Atlantic Home Health Network, Inc. is 80% owned by Oak Springs NursingHome Limited Liability Company.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Mid-Atlantic Home Health Network, Inc (MAHN) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.0800 versus a price of $0.5000 — about −84% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MAHN?
Our 21-model fair value for Mid-Atlantic Home Health Network, Inc is $0.0800 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.5000.
What is the quality score of MAHN?
Mid-Atlantic Home Health Network, Inc has a Quality Score of 85/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.